Gilead Sciences to Present at Upcoming Investor Conferences

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

• BofA Securities Health Care Conference on Tuesday, May 14 at 11:20am Pacific Time
• RBCCM Global Healthcare Conference on Wednesday, May 15 at 10:30am Eastern Time
• Jefferies Global Healthcare Conference on Wednesday, June 5 at 11:00am Eastern Time
• Goldman Sachs Annual Global Healthcare Conference on Wednesday, June 12 at 1:20pm Eastern Time

The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240430344533/en/

The Gilead Sciences Stock at the time of publication of the news with a fall of -1,09 % to 65,22EUR on Nasdaq stock exchange (30. April 2024, 21:55 Uhr).